The War Department's Office of Strategic Capital announced an $80 million conditional loan commitment with Antheia, Inc. to scale the company's domestic production of key starting materials and active pharmaceutical ingredients for generic pharmaceutical drugs.
Original sourceDepartment of Defense ReleasesSource attribution and the original dated record for this item.
Read original source 